Patient Capital Management Q3 2026 Commentary

Patient Capital Management reported its Q3 results, with net asset value (NAV) per share up 1.5% compared to the previous quarter.

The company's portfolio performed well, with strong contributions from its investments in healthcare and technology.

Patient Capital Management's stock price has been volatile in recent months, but the company remains optimistic about its long-term prospects.